About the conference
The Longevity Investors Conference gathers together a selected audience of the most prominent investors in the field.
The main aim of the events is to bring together academia and business to discuss the latest trends, and opportunities and to provide relevant insights into the longevity and rejuvenation subject.
The two full days conference is bringing together the world’s top longevity KOLs, institutional and private investors, wealthy private investors, family offices, and funds.
What is Longevity?
Longevity is the science of anti-aging research and rejuvenation.
It has experienced an unprecedented advance over recent years, particularly with the discovery that the rate of aging is controlled, at least to some extent, by genetic pathways and biochemical processes.
Longevity identifies both lifestyle and pharmaceutical targets to improve the human health-span (i.e.the time we can live without any negative impact from aging.)
Longevity will be one of the largest, if not the largest, investment opportunity in the decades to come.
Why join the LIC?
-
150 hand-picked guests (by application only)
-
Perfect networking opportunity with the best-in-field speakers.
-
Get acquainted with the latest and most attractive investment opportunities in the longevity field.
-
Establish strategic partnerships with other business leaders in one of a kind setting in 5*hotel in Gstaad, one of the most exclusive Swiss mountain resorts.
-
Get acquainted with and experience the latest trends related to personal longevity (supplements, therapies, and many more).

Private Investors (UHNWIs, Family Offices)

Institutional Investors (Asset Managers, PE Funds, VCs)

Academia

30+
Outstanding Speakers

150
Hand-picked guests (by application only)

2 full-days
Conference

LIC 2022 Highlights
Packages
LATE ARRIVAL
DELUXE ROOM
DELUXE ROOM
Package with accommodation at the Le Grand Bellevue Hotel.
SOLD OUT
Includes:
-
2-nights stay at the Le Grand Bellevue Hotel
-
3 breakfasts
-
2 lunches on Wednesday and Thursday
-
Networking dinner on Wednesday evening
-
Gala Dinner and Party on Thursday evening
-
Coffee breaks during the conference at Le Grand Bellevue
-
Transfer service during the conference days from Le Grand Bellevue to locations in Gstaad
-
Access to the LIC networking and matchmaking app
The package does NOT include:
-
Travel service to and from Gstaad
LATE ARRIVAL
CONFERENCE ONLY
CHIC ROOM
Package without accommodation.
Late Arrival Price: 4800 CHF
Includes:
-
2 lunches on Wednesday and Thursday
-
Networking dinner on Wednesday evening
-
Gala Dinner and Party on Thursday evening
-
Coffee breaks during the conference at Le Grand Bellevue
-
Transfer service during the conference days from Le Grand Bellevue to locations in Gstaad
-
Access to the LIC networking and matchmaking app
The package does NOT include:
-
Travel service to and from Gstaad
-
Accommodation
* If you are not in need of a room, please reach out to info@longevityinvestors.ch
Speakers
Take a look at the speakers line up (more to come).

David A. Sinclair, A.O., Ph.D.
Professor of Genetics at Harvard Medical School, President of the non-profit Academy for Health & Lifespan Research

Alex Zhavoronkov, Ph.D.
Founder and CEO, Insilico Medicine

Dr. Nir Barzilai, MD
Director, Institute for Aging Research, Albert Einstein College of Medicine

Dr. Eric Verdin
President & CEO, Buck Institute for Research on Aging

Bryan Johnson
Founder/CEO of Blueprint and Kernel & OS Fund. Previously founder/CEO of Braintree Venmo

Dr. Brian Kennedy, Ph.D.
Director, Centre for Healthy Longevity and Professor Departments of Biochemistry and Physiology, National University of Singapore

Dr. Andrew Steele
Scientist and author of Ageless: The new science of getting older without getting old

Michael Greve
Founder at Forever Healthy Foundation

Dr. Greg Bailey
Serial entrepreneur, founder and financier of biotech companies

David Gobel
CEO at Methuselah Foundation

Dr. Aubrey de Grey
Founder, President, and Chief Science Officer of LEV Foundation

Prof. Dr. Evelyne Yehudit Bischof, MD, MPH
Professor, internal medicine specialist, Longevity physician at Human Longevity Inc.

Joerg Rieker
Founding Partner at Maximon

Dr. Alexandra Bause
Co-Founder and Investment Director, Apollo Health Ventures

Prof. Dr. Collin Y. Ewald
Assistant Professor at ETH Zurich, Founder of Swiss Society for Aging Research

Amy B. Killen, MD
Longevity and regenerative medicine physician, entrepreneur, educator

Liz Parrish
Founder and CEO of BioViva

Dr. Antoinette Sarasin
Director of Biomolecular Restoration (BIO-R®), Nutrition & Lifestyle, Member of Board of Directors at The Kusnacht Practice

Felicia von Reden
Co-founder and CEO of Ovom Care

Dr. Emil Kendziorra
Founder and CEO of Tomorrow Bio and President of the Board at the European Biostasis Foundation

Dr. Dr. Elisabeth Roider, MD, PhD, MBA
Partner and Chief Scientific and Medical Officer, Maximon

Dr. Joris Deelen
Research Group Leader at the Max Planck Institute for Biology of Ageing

José Luis Cordeiro
Director, The Millennium Project and Vicechair, Humanity Plus

Tom Weldon
Founder, Chairman and CEO, Ponce De Leon Health

Dr. Kemal Tunc Tiryaki
Founder MAGE Group

Nawal Roy
Founder and CEO of Holmusk

Sophie Chabloz
Co-Founder and CPO, AVEA

Dr. Rob Konrad Maciejewski
Co-Founder and CEO, Biolytica

Dr. Arndt Rolfs, MD
CEO, Biolytica

Dr. Alex Colville
General Partner at the Longevity Fund

Bruno Balen
Chief Genius at AniBiome

Iva Hlapcic
PhD, Science Lead at Ani Biome
Moderators



Phil Newman
Founder, First Longevity, Editor-in-Chief Longevity.Technology



Sabinije von Gaffke
Head of Sustainability,
Nibiru Software AB
Hosts

Marc P. Bernegger
Founding Partner

Dr. Tobias Reichmuth
Founding Partner

Daniel Koetser
The Owner and Managing Director of Le Grand Bellevue Gstaad